Form 4: Veradermics CEO Sells Shares
Insider Transaction (Form 4)
Reid Alexander Waldman, Chief Executive Officer and a Director of Veradermics, Inc, sold 67,500 shares of common stock on August 17, 2026.
Summary
- Option exercise/conversion: acquired 3,452 Common Stock at $12.19 ($42,080) on August 17, 2026; holds 238,324 after (Direct).
- Open-market sale: disposed of 11,527 Common Stock at $106.72 ($1,230,161) on August 17, 2026; holds 226,797 after (Direct).
- Open-market sale: disposed of 25,234 Common Stock at $107.53 ($2,713,412) on August 17, 2026; holds 201,563 after (Direct).
- Open-market sale: disposed of 27,490 Common Stock at $108.45 ($2,981,290) on August 17, 2026; holds 174,073 after (Direct).
- Open-market sale: disposed of 3,000 Common Stock at $109.38 ($328,140) on August 17, 2026; holds 171,073 after (Direct).
- Open-market sale: disposed of 249 Common Stock at $111.28 ($27,709) on August 17, 2026; holds 170,824 after (Direct).
- Option exercise/conversion: disposed of 3,452 Stock Option (Right to Buy) on August 17, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $7,280,713 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Reid Alexander Waldman — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Option exercise/conversion | Common Stock | 3,452 | $12 | $42.1K | 238,324 |
| 2026-08-17 | Open-market sale | Common Stock | 11,527 | $107 | $1.2M | 226,797 |
| 2026-08-17 | Open-market sale | Common Stock | 25,234 | $108 | $2.7M | 201,563 |
| 2026-08-17 | Open-market sale | Common Stock | 27,490 | $108 | $3.0M | 174,073 |
| 2026-08-17 | Open-market sale | Common Stock | 3,000 | $109 | $328.1K | 171,073 |
| 2026-08-17 | Open-market sale | Common Stock | 249 | $111 | $27.7K | 170,824 |
| 2026-08-17 | Option exercise/conversion | Stock Option (Right to Buy) | 3,452 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Option exercise/conversion (3,452 shares) |
| 2026-08-17 | Open-market sale (11,527 shares) |
| 2026-08-17 | Open-market sale (25,234 shares) |
| 2026-08-17 | Open-market sale (27,490 shares) |
| 2026-08-17 | Open-market sale (3,000 shares) |
| 2026-08-17 | Open-market sale (249 shares) |
| 2026-08-17 | Option exercise/conversion (3,452 shares) |
Keywords
insider transaction, Form 4, MANE, Veradermics, Inc, bearish, Reid Alexander Waldman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.